lancome-peptide-cream Non-peptide antigens represent a distinct class of immune stimulants that play a crucial role in host defense, particularly in activating specific T cell populations. Unlike conventional peptide antigens, which are typically processed and presented by MHC molecules to alpha-beta T cells, non-peptide antigens can be recognized through different pathways, often involving gamma-delta (γδ) T cells or other unconventional T cell subsets. The ability of T cells to recognize non-peptide antigens highlights the diverse and sophisticated mechanisms employed by the immune system to detect and respond to a wide array of threats, including microbial pathogens and even certain drugs.
The study of non-peptide antigens has primarily focused on their interaction with human Vγ9/Vδ2 T cells, a major subset of γδ T cells found in peripheral blood. These T cells are known for their rapid response to various non-peptidic ligands, often without requiring the typical antigen processing and presentation steps associated with peptide antigensAntigen presentation to non-peptide-specific T cells. MR1 .... This unique recognition capability makes them vital in early immune responses against intracellular pathogens like Mycobacteria, where molecules such as isopentenyl pyrophosphate (IPP) and its analogs act as potent non-peptide antigens.
The recognition of non-peptide antigens by T cells differs significantly from the well-established MHC-restricted presentation of peptide antigens.BackgroundNon-protein antigen classes can be presented to T cellsby near-monomorphic antigen-presenting molecules such as CD1, MR1, and butyrophilin 3A1. Such ... While alpha-beta T cells typically engage peptide fragments bound to MHC class I or class II molecules, γδ T cells, and sometimes other T cell types, can recognize non-peptide antigens directly or through presentation by non-polymorphic molecules.
One key pathway involves CD1 proteins, a family of antigen-presenting molecules that are structurally related to MHC but present non-peptide antigens, particularly lipids and glycolipids, to T cells.CD1 presentation of microbial nonpeptide antigens to T cells. Human CD1b, for instance, is known to present microbial nonpeptide antigens to T cells. This mechanism allows the immune system to detect a broader range of foreign substances than would be possible through peptide recognition alone.NEO-PV-01 is a patient-personalizedpeptidevaccine, consisting of up to 20 synthetic neoantigen-targetingpeptidesidentified via a proprietary bioinformatics ...
Furthermore, some non-peptide antigens can be recognized independently of the Major Histocompatibility Complex (MHC). This is particularly true for γδ T cells, which can utilize receptors like the T-cell receptor (TCR) to directly bind to nonpeptide ligands. This MHC-independent recognition is a critical feature that allows for rapid activation and a broader scope of immune surveillance, especially in situations where conventional antigen presentation might be compromised or insufficient.
Non-peptide antigens originate from a variety of sources, encompassing both endogenous and exogenous molecules作者：SA Porcelli·1996·被引用次数：124—Studies of two distinct human T-cell systems have provided the exciting finding that T cells are able to recognizenon-peptide antigens.. Microbial metabolites are a significant category, with isopentenyl pyrophosphate (IPP) and its synthetic analogs being well-characterized examples that activate human Vγ2Vδ2 T cells.Non-peptidelipidantigenshave been shown to be presented to T-cells by human CD1 proteins, a family of nonpolymorphic glycoproteins encoded outside of the ... These molecules are often produced by bacteria, such as Mycobacteria, and their recognition by T cells contributes to host defense against infection.Direct presentation of non-peptide prenyl pyrophosphate ...
Beyond microbial products, non-peptide antigens can also include small molecular compounds, such as certain drugs. These drugs can act as non-peptide antigens, eliciting T cell responses and potentially leading to immune-mediated reactions or therapeutic effects. Understanding how these drugs are presented to T cells is crucial for predicting and managing their immunogenicity.作者：S von Greyerz·1998·被引用次数：23—Drugs arenon-peptide antigensthat can be recognized by specific T cells. It has been thought for many years that small molecular compounds can only be ...
Lipid antigens also fall under the umbrella of non-peptide antigens and are presented by CD1 moleculesT cell recognition of non-peptidic antigens in infectious diseases. This class of antigens expands the repertoire of immune recognition, allowing the immune system to respond to the lipid components of pathogens or other foreign entities. The diversity of non-peptide antigens underscores the multifaceted nature of immune surveillance and the constant evolutionary pressure shaping host-pathogen interactions.
The recognition of non-peptide antigens by specific T cell populations has significant implications for various aspects of immunology, including host defense against infections, autoimmune diseases, allergies, and tumor immunosurveillance. The rapid activation of γδ T cells by non-peptide antigens provides an early line of defense against microbial pathogens. Their ability to produce cytokines and cytotoxic molecules can help control infections before a more specific adaptive immune response is mounted.
In the context of infectious diseases, non-peptide antigens derived from pathogens can trigger potent T cell responses that are crucial for pathogen clearanceIdentification of antigen-presenting cell–T cell interactions .... For example, the recognition of mycobacterial non-peptide antigens by Vγ2Vδ2 T cells plays a vital role in controlling infections caused by Mycobacteria.
Furthermore, dysregulation in the recognition or presentation of non-peptide antigens can contribute to the development of autoimmune diseases and allergies. Conversely, harnessing the immune response mediated by non-peptide antigens holds promise for therapeutic applications, such as cancer immunotherapy作者：M Poupot·2004·被引用次数：101—Variousnon-peptidic ligands which specifically activate most of circulating human Vγ9/Vδ2 T lymphocytes are now known. Most of these are so-called .... The potent anti-tumor activity observed in Vγ2Vδ2 T cells, often driven by non-peptide antigens, is an area of active research for developing novel cancer treatments.
In conclusion, non-peptide antigens represent a critical component of the immune system's repertoire, enabling the recognition and response to a diverse array of stimuli beyond traditional protein fragments. Their unique recognition mechanisms, particularly by γδ T cells and through CD1 presentation, highlight the intricate ways in which the immune system maintains homeostasis and defends against threatsPresentation of non-peptide antigens, in particular drugs, to .... Continued research into non-peptide antigens promises to deepen our understanding of immune function and unlock new therapeutic strategies.
Join the newsletter to receive news, updates, new products and freebies in your inbox.